According to the latest market analysis by Future Market Insights, the global nasal sprays market is poised for consistent ...
Despite its scale, steatotic liver disease remains largely absent from global and US noncommunicable disease strategies.
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in ...
According to the latest market analysis by Future Market Insights, the global nasal sprays market is poised for consistent expansion, supported by ...
If the government wants to pay more for medicines as part of its trade policy it should fund that choice explicitly, say ...
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with high-risk smoldering multiple myeloma, according to results from ...
BioVersys and partners publish in the prestigious journal of Nature Communications pre-clinical development data of AlpE (alpibectir and ethionamide), an innovative drug combination that overcomes ...
Dawe, PhD, as Scientific Advisor, Neuropharmacology & Translational Neuroscience, and Tomi K. Sawyer, PhD, as Strategic ...
From a design perspective, it is difficult to truly integrate a data centre into a mixed-use campus — security needs to be ...
A single infusion of ciltacabtagene autoleucel (Carvykti) led to a 100% minimal residual disease (MRD)-negativity rate in patients with ...
Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors ...
Biotech executives, investors, and R&D leaders all face the same burning question in 2026: How do we scale breakthroughs from the lab to the global market without getting stuck in commercia | Join ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results